Keri McFarlane
Family Medicine · Knoxville, TNNPI 1588688998
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $607 and has fallen 67.8% since, to $195 in 2023.
Across 120 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$300
- Novo Nordisk$199
- Otsuka America Pharmaceutical, Inc.$180
- Teva Pharmaceuticals USA, Inc.$116
- AbbVie$102
- Johnson & Johnson$101
- plus $929 from 22 others
What the payments were for
- Food & beverage$1,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 21 | $300 |
| Novo Nordisk | 13 | $199 |
| Otsuka America Pharmaceutical, Inc. | 10 | $180 |
| Teva Pharmaceuticals USA, Inc. | 7 | $116 |
| AbbVie(2 entities) | 6 | $102 |
| Johnson & Johnson | 5 | $101 |
| Amgen(2 entities) | 7 | $98 |
| E.r. Squibb & Sons, L.L.C. | 5 | $90 |
| Sanofi | 5 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $62 |
| AstraZeneca | 4 | $61 |
| Neurelis, Inc. | 3 | $61 |
| Biohaven Pharmaceuticals, Inc. | 3 | $48 |
| Acadia Pharmaceuticals Inc | 3 | $47 |
| Pfizer | 2 | $38 |
| CSL Behring | 2 | $31 |
| Upsher-smith Laboratories LLC | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Merck | 2 | $25 |
| UCB, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $12 |
How this compares
$1,927 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Knoxville
- Jerry PunchKnoxville$45K
- David CrouchKnoxville$16K
- Rickey ManningKnoxville$14K
- Paul WakefieldKnoxville$14K
- Justin QuinnKnoxville$14K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.